Literature DB >> 4040890

Effect of aztreonam on the colon microflora in patients undergoing colorectal surgery.

L Kager, B Brismar, A S Malmborg, C E Nord.   

Abstract

Aztreonam was given intravenously at a dose of 1 g at induction of anaesthesia, followed by subsequent doses of 1 g at eight hour intervals during 48 hours to 20 patients undergoing colorectal surgery. A series of serum and faecal specimens were taken for analysis of aztreonam concentrations. Tissue samples from the gut wall were taken at surgery. The maximum serum concentrations (mean value 114.7 mg/l) during surgery were reached 15 minutes after aztreonam administration. The aztreonam concentration in the tissue samples varied from 4.1-28.3 mg/kg and the concentration in the faecal samples from 0.4-34.4 mg/kg. Faecal samples were also collected during the investigation period for cultivation of aerobic and anaerobic bacteria. Enterobacteria were suppressed significantly during the prophylaxis period and there was a significant increase of staphylococci in ten of the patients. Three of these patients developed postoperative wound infections with staphylococci. Among the anaerobic bacteria, only minor changes were observed during the same period. After two weeks, the microflora was normalized in all patients. Five postoperative infections including an anastomose dehiscence in one patient occurred.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4040890     DOI: 10.1007/bf01642868

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  7 in total

1.  WOUND SEPSIS AFTER CLEAN OPERATIONS.

Authors:  U LJUNGQVIST
Journal:  Lancet       Date:  1964-05-16       Impact factor: 79.321

Review 2.  Impact of antimicrobial agents on the gastrointestinal microflora and the risk of infections.

Authors:  C E Nord; L Kager; A Heimdahl
Journal:  Am J Med       Date:  1984-05-15       Impact factor: 4.965

3.  Biliary excretion of aztreonam in patients with biliary tract disease.

Authors:  O V Martinez; J U Levi; R G Devlin
Journal:  Antimicrob Agents Chemother       Date:  1984-03       Impact factor: 5.191

4.  Azthreonam (SQ 26,776), a synthetic monobactam specifically active against aerobic gram-negative bacteria.

Authors:  R B Sykes; D P Bonner; K Bush; N H Georgopapadakou
Journal:  Antimicrob Agents Chemother       Date:  1982-01       Impact factor: 5.191

5.  Enterococcal superinfection and colonization with aztreonam therapy.

Authors:  P H Chandrasekar; B R Smith; J L LeFrock; B Carr
Journal:  Antimicrob Agents Chemother       Date:  1984-08       Impact factor: 5.191

6.  Metabolism and pharmacokinetics of aztreonam in healthy subjects.

Authors:  E A Swabb; S M Singhvi; M A Leitz; M Frantz; A Sugerman
Journal:  Antimicrob Agents Chemother       Date:  1983-09       Impact factor: 5.191

7.  Antibiotic prophylaxis with cefoxitin in colorectal surgery: effect on the colon microflora and septic complications--a clinical model for prediction of the benefit and risks in using a new antibiotic in prophylaxis.

Authors:  L Kager; I Ljungdahl; A S Malmborg; C E Nord; R Pieper; P Dahlgren
Journal:  Ann Surg       Date:  1981-03       Impact factor: 12.969

  7 in total
  5 in total

1.  Effect of antibiotic treatment on growth of and toxin production by Clostridium difficile in the cecal contents of mice.

Authors:  Nicole J Pultz; Curtis J Donskey
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

2.  Modulation of the intestinal flora of mice by treatment with aztreonam and tigemonam.

Authors:  M L van Ogtrop; H F Guiot; H Mattie; E van Strijen; B R Sekh; R van Furth
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191

3.  Effects of broad-spectrum antimicrobial agents on yeast colonization of the gastrointestinal tracts of mice.

Authors:  G Samonis; E J Anaissie; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1990-12       Impact factor: 5.191

4.  Prospective evaluation of effects of broad-spectrum antibiotics on gastrointestinal yeast colonization of humans.

Authors:  G Samonis; A Gikas; E J Anaissie; G Vrenzos; S Maraki; Y Tselentis; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1993-01       Impact factor: 5.191

5.  Effect of broad-spectrum parenteral antibiotics on composition of intestinal microflora of humans.

Authors:  M Giuliano; M Barza; N V Jacobus; S L Gorbach
Journal:  Antimicrob Agents Chemother       Date:  1987-02       Impact factor: 5.191

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.